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Abstract
Stunting prevalence is an indicator of a country’s progress
towards United Nations’ Sustainable Development Goal
2, which is to end hunger and achieve improved nutrition.
Accelerating progress towards reducing stunting requires
a deeper understanding of the factors that contribute
to linear growth faltering. We conducted path analyses
of factors associated with 18-month length-for-age
z-score (LAZ) in four prospective cohorts of children who
participated in trials conducted as part of the International
Lipid-Based Nutrient Supplements Project in Ghana
(n=1039), Malawi (n=684 and 1504) and Burkina Faso
(n=2619). In two cohorts, women were enrolled during
pregnancy. In two other cohorts, infants were enrolled
at 6 or 9 months. We examined the association of 42
indicators of environmental, maternal, caregiving and
child factors with 18-month LAZ. Using structural equation
modelling, we examined direct and indirect associations
through hypothesised mediators in each cohort. Out of 42
indicators, 2 were associated with 18-month LAZ in three
or four cohorts: maternal height and body mass index
(BMI). Six factors were associated with 18-month LAZ
in two cohorts: length for gestational age z-score (LGAZ)
at birth, pregnancy duration, improved household water,
child dietary diversity, diarrhoea incidence and 6-month or
9-month haemoglobin concentration. Direct associations
were more prevalent than indirect associations, but
30%–62% of the associations of maternal height and
BMI with 18-month LAZ were mediated by LGAZ at birth.
Factors that were not associated with LAZ were maternal
iron status, illness and inflammation during pregnancy,
maternal stress and depression, exclusive breast feeding
during 6 months post partum, feeding frequency and child
fever, malaria and acute respiratory infections. These
findings may help in identifying interventions to accelerate
progress towards reducing stunting; however, much of the
variance in linear growth status remained unaccounted
for by these 42 individual-level factors, suggesting that
community-level changes may be needed to achieve
substantial progress.

Key question
What is already known?
►► Previous cross-sectional studies have identified key

risk factors for stunted growth, including being small
for gestational age at birth, poor sanitation, childhood diarrhoea, and low dietary diversity and infrequent infant feeding.

What are the new findings?
►► We found consistent associations of 18-month

length-for-age z-scores (LAZ) with maternal height
and maternal body mass index.
►► The factors with the strongest associations with
18-month LAZ were length for gestational age
z-score (LGAZ) at birth, maternal height and gestational age at birth.
►► Other factors that showed significant associations
with 18-month LAZ (although with smaller coefficients), were improved household water source, child
dietary diversity, childhood diarrhoea incidence and
6-month or 9-month haemoglobin concentration.

What do the new findings imply?
►► Interventions targeting these factors associated

with LAZ may accelerate progress towards reducing stunting; however, much of the variance in linear
growth status remained unaccounted for by individual-level factors, suggesting that community-level
changes may be needed to achieve substantial progress and further research is needed to understand
the causes of stunting.

Introduction
Linear growth faltering during early life is
associated with later health conditions, such
as cardiometabolic disease,1 and poor cognitive and school performance.2 Stunting
occurs when children falter in linear growth
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the population.13 If between-population differences are
more meaningful than within-population differences
between individuals, then we would expect the pooled
analysis to account for more variance than the analyses
of each separate cohort.
Methods
Based on several previous frameworks,5 6 14 we developed a conceptual path model of potential influences
on 18-month linear growth status (figure 1). We tested
the following pathways, which correspond to the labels
of the arrows in figure 1.
Pathway (1)
At an individual level, maternal height may be related
to the child’s genetic potential for adult height that can
be attained. In populations with a high prevalence of
stunting, maternal height is also partly a reflection of
growth restriction experienced by the mother during
early life. Therefore, inclusion of maternal height
in the model served two purposes: first, to adjust for
a proxy of genetic potential, and second, to test the
pathway that intergenerational effects of maternal
growth during early life, reflected by maternal adult
height, on child linear growth may be mediated by
(1.1) socioeconomic conditions of the current generation, (1.2) maternal adult factors (nutritional status,
illness, stress, depression, cognition), (1.3) caregiving
practices, (1.4) child factors or (1.5) may directly affect
linear growth (arrows for each individual pathway not
drawn in the figure).
Pathway (2)
Socioeconomic disparities and other environmental
effects on child linear growth may be mediated by (2.1)
maternal factors, (2.2) caregiving practices, (2.3) child
factors or (2.4) may directly affect linear growth.
Pathway (3)
Effects of maternal factors on child growth may be
mediated by (3.1) child factors, (3.2) caregiving practices or (3.3) may directly affect child growth.
Pathway (4)
Effects of infant feeding practices on child growth may
be mediated by child factors (4.1) or caregiving practices may directly affect child growth (4.2).
Pathway (5)
Effects of preterm birth or intrauterine growth restriction on later child linear growth status may be mediated by (5.1) postnatal child factors (appetite, illness,
haemoglobin (Hb)/iron status, physical activity, stress)
or (5.2) may be direct effects.
Pathway (6)
Effects of child factors (appetite, illness, Hb/iron
status, physical activity, stress) on child growth (6.1)
Prado EL, et al. BMJ Glob Health 2019;4:e001155. doi:10.1136/bmjgh-2018-001155
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early in life and is defined as height-for-age >2 SD
below the median of the WHO Child Growth Standards.3 Stunting prevalence is an important indicator to
evaluate a country’s progress towards United Nations’
Sustainable Development Goal 2, which is to end
hunger and achieve improved nutrition by 2030. From
2000 to 2017, the estimated number of stunted children under 5 years of age globally decreased from 198
million to 151 million.4 Accelerating progress towards
reducing the prevalence of stunting requires a more
advanced understanding of the factors that contribute
to early linear growth faltering.
Several previous reviews have summarised these risk
factors,5–7 identifying environmental factors such as
household food insecurity and poor quality water and
sanitation; maternal factors such as short stature and
poor nutrition and health during pregnancy; caregiving factors, such as infrequent feeding and low
dietary diversity; and child factors such as being born
preterm, small for gestational age and childhood diarrhoea incidence. Frameworks that describe the determinants of childhood malnutrition5 6 recognise that
distal factors (eg, community, household level) operate
through more proximal factors (eg, maternal, child
level) in their influence on growth faltering. However,
most studies that have attempted to quantify the relative contribution of risk factors for linear growth
faltering have used cross-sectional analyses, such as
the estimation of regression coefficients8–10 or population-attributable fraction.11 12 These methods describe
direct associations, but do not account for the indirect
associations of distal factors through proximal factors.
In the current study, we performed a set of path analyses of factors associated with linear growth status at
age 18 months in four longitudinal cohorts of children
(n=5846) who participated in the International LipidBased Nutrient Supplements (iLiNS) Project in Ghana,
Malawi and Burkina Faso. The first objective was to
identify the factors associated with 18-month linear
growth status, reflecting cumulative linear growth
during gestation and the first 18 months after birth, in
each iLiNS cohort. The second objective was to identify
the pathways through which these factors operate. The
prospective design enabled examination of factors associated with linear growth throughout most of the first
1000 days after conception. Harmonisation of many of
the variables across cohorts allowed examination of the
same factors and pathways in different contexts.
Finally, our third objective was to determine whether
a pooled analysis examining predictors of 18-month
length-for-age z-score (LAZ) across cohorts accounted
for more variance in LAZ than the within-cohort
models. Evidence suggests that linear growth faltering
is a whole-population phenomenon. In populations
with a high prevalence of stunting, it is not the case
that a subgroup of that population is faltering while the
rest are growing normally, but instead there is usually
a downward shift in the entire height distribution of
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Conceptual model.

may be mediated by caregiving behaviour in response
to these factors, or (6.2) may be direct effects.
iLiNS project trial designs
In the iLiNS-DYAD-G trial in Ghana (n=1320) and the
iLiNS-DYAD-M trial in Malawi (n=869), pregnant women
were enrolled at ≤20 weeks of gestation. In the iLiNSDOSE trial in Malawi (n=1932) and iLiNS-ZINC trial in
Burkina Faso (n=3220), infants were enrolled at age 6
and 9 months, respectively. All participants were assigned
to receive various doses and formulations of lipid-based
nutrient supplements (LNS), or to control groups until
age 18 months, when length was measured.15–18 The
effects of the interventions on 18-month child length-for
LAZ differed across trials, with positive effects in Burkina
Faso17 and Ghana,15 but not in Malawi.16 18 For further
information, see supplemental methods.
Participants
In the path analyses reported here, we included all
children for whom LAZ at age 18 months was available,
Prado EL, et al. BMJ Glob Health 2019;4:e001155. doi:10.1136/bmjgh-2018-001155

comprising 1039 children in iLiNS-DYAD-G, 684 in
iLiNS-DYAD-M, 1504 in iLiNS-DOSE and 2619 children
in iLiNS-ZINC.
Procedure
Detailed reports of the data collection procedures in
each trial have been published elsewhere15–18; therefore, we summarise the procedures for collection of
variables that were used in the analyses presented here.
Online supplementary table 1 presents further details
of the data collection procedures and variable definitions. Figure 2 shows the data collection schedule for
each variable in each cohort.
Data on socio-demographic characteristics and
maternal anthropometric status were gathered at enrolment. In the two DYAD trials, maternal pre-pregnancy
body mass index (BMI) was estimated based on BMI
and gestational age at enrolment. Capillary or venous
blood samples were collected from mothers and/or
children at multiple time points for the assessment of
3
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Figure 1
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Data collection timeline in each cohort.

(1) malaria using a rapid diagnostic test, (2) Hb concentration (g/L), (3) biomarkers of iron status, including
zinc protoporphyrin (ZPP) concentration (μmol/mol
heme), and soluble transferrin receptor (sTfR, mg/L),
and (4) biomarkers of inflammation, including alpha1-acid glycoprotein (AGP; g/L) concentration. In
ZINC, known HIV infection was an exclusion criterion,
but HIV was not tested; therefore, HIV status of women
who were enrolled was unknown. In DOSE, HIV status
was also unknown. In DYAD-G, HIV infection was
known from antenatal cards and HIV-positive women
were excluded. In DYAD-M, women were tested for HIV
at enrolment but were not excluded.
Maternal and/or child saliva samples in DYAD-M
and DYAD-G were collected at several time points for
the measurement of cortisol concentration (nmol/L).
Maternal self-reported stress was measured in DYAD-M
at multiple time points using the Perceived Stress
Scale.19 20 Mothers were interviewed regarding depressive symptoms at 6 months post partum in DYAD-M
using a locally validated adaptation of the Self-Reporting Questionnaire and in DYAD-G with the Edinburgh Post-natal Depression Scale.21 In DYAD-M, at 6
months post partum, maternal cognition was assessed
using digit span forward and backward, verbal fluency,
mental rotation and functional health literacy tests.22
Children were visited weekly for morbidity surveillance. At these visits, caregivers were asked whether
4

the child experienced any illness symptoms, including
fever, diarrhoea, vomiting, cough, nasal discharge,
respiratory distress or poor appetite during the past
seven days and/or data collectors measured the child’s
auricular temperature. Longitudinal prevalence and/
or incidence of diarrhoea, fever, malaria, acute respiratory infection and/or poor appetite were calculated
(online supplementary table 1). In DOSE and DYAD-M,
physical activity at age 18 months was measured over
1 week with the hip-worn ActiGraph GT3X+accelerometer (Pensacola, Florida, USA).23
Infant feeding practices were assessed at multiple
time points through qualitative 24 hours and/or 7-day
dietary recall questionnaires.24 In all four trials, developmental stimulation was measured at age 18 months
using the Family Care Indicators interview.25 The
mother was interviewed with regard to the variety of
play materials and activities that adults used to engage
with the child in the past three days.
In DYAD-G and DYAD-M, gestational age at enrolment
was mainly determined by ultrasound and this was used
to calculate gestational age at birth. In DYAD-G, infant
weight and length were measured within 48 hours of
birth or between 3 and 14 days after birth for 87 (9.4%)
when the former was not possible. In DYAD-M, infant
weight and length were measured within 6 weeks of
birth. We estimated length and weight at birth based
on LAZ and WAZ measured within 6 weeks of birth,
Prado EL, et al. BMJ Glob Health 2019;4:e001155. doi:10.1136/bmjgh-2018-001155
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Figure 3

Mediation analysis.

assuming that LAZ and WAZ did not change from birth
to the time of measurement. Length and weight for
gestational age at birth z-scores were then calculated
based on the INTERGROWTH-21st standards.26 In all
four cohorts, length was measured at age 18 months. All
length measurements were conducted to the nearest 1
mm by teams of two trained and standardised anthropometrists using length boards.
Analysis
We examined the distribution of each independent
variable separately by cohort. We log-transformed
skewed variables and winsorised outliers to the 1st and
99th percentile. If transformation did not result in a
normal distribution, we created a binary variable. All
continuous variables were standardised to SD units by
subtracting the mean and dividing by SD.
We performed exploratory mediation analyses
according to the following steps. We refer to figure 3 to
describe each step in the mediation analysis.
Step 1: variable selection
The first condition for inclusion in our mediation
analysis was that X is associated with Y, represented
by c in figure 3, so we examined independent associations between each predictor and 18-month LAZ and
dropped any that were not associated at p<0.05. The
second condition was that X is associated with M, represented by a. The third condition was that M is associated with Y, represented by b. In this first step, we tested
the significance of b and c.
Second, we reduced the number of variables
measuring the same construct by eliminating variables that were collinear. If two variables were highly
collinear (r>0.6), we dropped the one that was less
strongly associated with 18-month LAZ. Third, we
Prado EL, et al. BMJ Glob Health 2019;4:e001155. doi:10.1136/bmjgh-2018-001155

Step 2: path selection
For each pathway in figure 1, we examined the association between each pair of variables on the pathway
to determine which variables were potential mediators.
In this second step, we tested the significance of a in
figure 3 and dropped any pathways for which p>0.05.
In figure 1, unidirectional arrows represent pathways
tested. Bidirectional arrows represent associations that
were checked for collinearity, but were not otherwise
modelled in the path analysis. All analyses up to this
point were conducted using SAS V.9.4 (SAS Institute).
Next, for each independent variable with potential
mediators, we tested the mediation model using Stata
V.14.1 (StataCorp) binary mediation program. We ran
the multiple mediation model including all potential
mediators together, rather than testing each mediator
one by one in separate models. In the final path model,
we included all pathways for which the indirect association of X with Y through M was significant. If the
interaction between X and M was significant at p<0.05,
we stratified the sample at the median of the independent variable and tested the indirect association of
X through M at both high and low levels of X. If the
indirect association was significant at both high and low
levels of X, then we retained the pathway in the model;
otherwise, we removed that pathway.
Finally, we ran the final path model using the sem
command in Stata with the mlmv option to estimate the
model on the full data set using maximum likelihood
estimation for missing values. All models controlled
for three covariates: randomly assigned trial group
(LNS vs no LNS), child sex and child age at 18-month
LAZ assessment. In the final models, we corrected p
values for multiple comparisons using the Benjamini-Hochberg correction,27 which is recommended for
controlling the false discovery rate in structural equation models.28 We applied the correction separately for
each model (ie, for each cohort). If any pathway was
not significant at corrected p<0.05, then we did not
draw that pathway in the path diagram.
For objective 3, we examined the 16 variables
that were available in all four cohorts: household
asset index, household food insecurity access index,
maternal and paternal education, household water
and toilet, maternal age, height, and BMI, child diarrhoea and fever prevalence, child 6-month or 9-month
5
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examined four multivariate models with each category of factors together predicting 18-month LAZ and
dropped any that were not associated at p<0.05. If, at
this step, no variable was significantly associated when
controlling for the others, we retained the one that was
most strongly associated with 18-month LAZ. The four
multivariate models were (1) all environmental factors
together, (2) all maternal factors together, excluding
maternal height, (3) all caregiving factors together and
(4) all child factors together, excluding gestational age
at birth and LGAZ at birth.

BMJ Global Health

Results
Summary statistics for all independent variables are
presented in online supplementary table 2. The variable
selection results are shown in online supplementary table
3-6. The pathway selection results are shown in online
supplementary table 7-10. At age 18 months, the mean
(SD) LAZ in each cohort was −0.8 (1.0) in DYAD-G, −1.7
(1.1) in DYAD-M, −1.9 (1.1) in DOSE and −1.5 (1.1) in
ZINC. The percentage of children who were stunted
(LAZ < −2) at age 18 months in each cohort was 12%
in DYAD-G, 31% in DYAD-M, 43% in DOSE and 32% in
ZINC.
Among environmental variables, 18-month LAZ
was positively associated with higher household assets
(DYAD-G), household being located closer to the market
(DOSE), higher maternal education (DOSE, ZINC),
higher paternal education (DYAD-M) and an improved
water source (DOSE, ZINC). Of the maternal variables,
we observed higher LAZ among children of mothers who
were taller in all four cohorts and among children of
mothers who had higher BMI in three cohorts (DYAD-M,
DOSE, ZINC). In DYAD-G, higher LAZ was associated
with higher maternal Hb at ≤20 weeks gestation. Among
the caregiving variables, we observed higher LAZ among
children who had greater dietary diversity (at 15 months
in DOSE and at 9 months in ZINC), higher 18-month
variety of play materials (DYAD-M, ZINC) or higher
18-month activities with caregivers (DYAD-M).
Of the child variables, higher LAZ was associated with
higher Hb at 6 (DYAD-M, DOSE) or 9 months (ZINC),
greater positive change in Hb from 9 to 18 months
(ZINC), lower 18-month AGP (DYAD-M), lower diarrhoea incidence from 6 (DOSE) or 9 (ZINC) to 18
months, lower prevalence of poor appetite from 6 to 18
months (DYAD-G) and higher activity levels as measured
by accelerometer mean vector magnitude at 18 months
(DOSE). In the two cohorts enrolled before birth, both
gestational age at birth and LGAZ at birth were strongly
associated with 18-month LAZ. All coefficients in the
final models are presented in figure 4 and online supplementary table 11 .
Regarding pathway (1), examination of genetic effects
or intergenerational effects of maternal growth during
early life, reflected by maternal adult height, on child
18-month LAZ consistently showed that this was largely a
direct association (66%–99% of the association between
maternal height and LAZ across the four cohorts)
rather than via mediation by other factors. In the two
cohorts in which length at birth was measured, LGAZ
6

at birth mediated a substantial proportion of this association (34% in DYAD-G, 30% in DYAD-M). A very small
proportion of this association was mediated by child Hb
at 6 months (2% in DOSE) or dietary diversity in infant
feeding (1% in ZINC).
For pathway (2), the extent to which socioeconomic
disparities were mediated by other factors varied across
cohorts and independent variables, from 0% to 43%.
In ZINC, the association of maternal education with
18-month LAZ was mediated by the child’s variety of play
materials (43%) and the association of improved water
source with LAZ was not mediated by any other variables. In DYAD-G, the association between household
assets and child LAZ was partly mediated by maternal
lower Hb concentration in early pregnancy (17%) and
gestational age at birth (11%). In DOSE, three environmental variables were associated with LAZ: distance
to the nearest market, maternal education and an
improved water source. The direct proportion of these
associations ranged from 74% to 93%. The association
of distance to the nearest market with LAZ was partly
mediated by maternal BMI (11%) and child diarrhoea
incidence (5%). The association of maternal education
with 18-month LAZ was partly mediated by maternal BMI
(7%). The association of improved water source with
child LAZ was partly mediated by child physical activity
(26%). In DYAD-M, while the association of paternal
education with LAZ was retained in the variable selection
process, it was not significant in the final model and was
not mediated by any variables.
Regarding pathway (3), the extent to which associations
of maternal health and nutritional status with child LAZ
were mediated versus direct effects also varied by cohort
and independent variable (0%–56%). In DYAD-M, the
association between maternal BMI and 18-month LAZ
was largely mediated by LGAZ at birth (62%). In the two
cohorts in which LGAZ at birth was not available, the
association of maternal BMI with LAZ was largely a direct
association (92%–94%), with a small proportion mediated by the child’s variety of play materials (8% in ZINC)
or child Hb concentration at 6 months (6% in DOSE).
In DYAD-G, the association of maternal Hb in early pregnancy with 18-month LAZ was not mediated by any other
variables.
Associations of dietary diversity in infant feeding at 9
months in ZINC and 15 months in DOSE with 18-month
LAZ (pathway 4.1) were partly mediated by child diarrhoea incidence. Caregivers who reported higher dietary
diversity in infant feeding also reported higher diarrhoea
incidence in the child. The association of dietary diversity
with 18-month LAZ was also positive and the association
of diarrhoea incidence with 18-month LAZ was negative;
therefore, the proportion of the association between
dietary diversity and child LAZ that was mediated by diarrhoea incidence was negative (−5% in ZINC and −28%
in DOSE).
Results from both trials that measured gestational
age and length at birth showed that these were direct
Prado EL, et al. BMJ Glob Health 2019;4:e001155. doi:10.1136/bmjgh-2018-001155
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Hb and ZPP, mean dietary diversity across time points,
variety of play materials and activities with caregivers
at age 18 months. We report the R2 in the models with
these 16 predictors in each cohort separately and in the
pooled model to determine whether the pooled analysis accounted for more variance in 18-month LAZ than
the within-cohort models.

BMJ Global Health

associations, unmediated by any other child factors
(pathway 5.2). The following results from the ZINC
cohort supported pathway (6.1): children with lower Hb
at age 9 months were provided with lower variety of play
materials at 18 months, mediating 12% of the association
with 18-month LAZ. Similar to dietary diversity, variety
of play materials was positively associated with diarrhoea
incidence, therefore this mediated −8% of the negative
association between diarrhoea incidence and child LAZ.
The final models accounted for 34% of the variance
in 18-month LAZ in DYAD-G, 37% in DYAD-M, 17% in
DOSE and 20% in ZINC. Overall, maternal and child
factors showed stronger associations with 18-month LAZ
compared with environmental and caregiving factors,
Prado EL, et al. BMJ Glob Health 2019;4:e001155. doi:10.1136/bmjgh-2018-001155

even when considering both indirect and direct effects
(figure 5).
For objective 3, the 16 variables common across all
four cohorts accounted for the following percentage
of variance in 18-month LAZ: 16% in DYAD-G, 21% in
DYAD-M, 15% in DOSE, 19% in ZINC, and 25% in the
pooled analysis. Of these 16 variables, maternal height
accounted for the largest proportion of variance in
18-month LAZ: 11% in DYAD-G, 14% in DYAD-M, 10%
in DOSE, 11% in ZINC and 9% in the pooled analysis.
Therefore, excluding maternal height, environmental,
maternal, caregiving and child factors accounted for only
5%–8% of variance in LAZ in the individual cohorts and
16% in the pooled analysis.
7
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Figure 4 Path diagram of factors associated with18-month LAZ in four iLiNS cohorts. 1Measured in one cohort. 2Measured
in two cohorts. 3Measured in three cohorts. AGP, alpha-1-acid glycoprotein; BMI, body mass index; Hb, haemoglobin; iLiNS
International Lipid-Based Nutrient Supplements; LAZ, length-for-age z-score.
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Discussion
In four prospective cohorts of children, we conducted
path analyses of environmental, maternal, caregiving and
child factors hypothesised to be associated with 18-month
linear growth status. Out of 42 indicators examined, only
2 indicators emerged as consistent predictors of 18-month
LAZ in 3–4 cohorts: maternal height and maternal BMI.
Two additional factors, which were only measured in the
two pregnancy cohorts, were significantly associated with
18-month LAZ in both cohorts in which they were measured: LGAZ at birth and gestational age at birth. In the
two cohorts enrolled after birth, four factors were significantly associated with 18-month LAZ in both cohorts:
improved household water source, dietary diversity in
infant feeding, childhood diarrhoea incidence and
6-month or 9-month Hb. Overall, maternal and child
factors showed stronger and more consistent associations with child LAZ than environmental and caregiving
factors, even when considering both indirect and direct
effects.
While specific pathways differed across cohorts, in
general direct associations were stronger and more prevalent than indirect associations. The strongest evidence
for mediation was the finding that 62% of the association
of maternal BMI with 18-month LAZ was mediated by
LGAZ at birth in DYAD-M. This underscores the importance of maternal nutritional status for fetal growth, with
lasting consequences for growth status later in childhood.
LGAZ at birth also mediated a substantial proportion of
the association of maternal height with 18-month LAZ
8

(30%–34%) in both cohorts in which it was measured
(DYAD-M and DYAD-G). This pathway is likely to reflect
genetic influences, at least in part, and therefore may be
only partly modifiable. In the two cohorts in which LAZ
at birth was not measured (DOSE and ZINC), the association of maternal height with 18-month LAZ was a direct
association.
Of the eight key risk factors closely associated with linear
growth faltering that we found, three were consistently
identified in previous studies that examined the relative
contribution of risk factors to stunting prevalence globally: fetal growth restriction, diarrhoea and low dietary
diversity. Danaei et al used population surveys to estimate
cases of stunting attributable to 18 risk factors in 137
developing countries, including indicators of maternal
nutrition and infection, teenage motherhood and short
birth intervals, fetal growth restriction and preterm birth,
child nutrition and infection, and environmental factors.
They found that a large number of stunting cases were
attributable to being born small for gestational age at term
(10.8 million, 24% of cases), followed by poor sanitation
(7.2 million, 16% of cases) and diarrhoea (5.8 million,
13% of cases).11 In a systematic review, Mosites et al calculated the population-attributable fraction of stunting for
five categories of risk factors: low birth weight, insufficient diet, enteric dysfunction, infection and toxin exposure. They estimated that 25% of global stunting could
be attributed to child diarrhoea incidence. In Africa, the
largest number of stunting cases was attributable to low
dietary diversity, low feeding frequency, or both (30%).12
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Figure 5 Coefficients of direct and indirect effects on 18-month LAZ in the final structural equation models. BMI, body mass
index; Hb, haemoglobin; LAZ, length-for-age z-score.
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SD below the WHO median by age 18 months. Another
potential reason is that we did not measure community-level or social factors that may contribute to children’s
growth faltering at a population level. For example,
several studies have found that community-level sanitation coverage predicts child growth more strongly than
household-level sanitation.29 30
Strengths of the study were the large number of children in each cohort, the large number of variables
examined and the availability of data from four cohorts
of children in three African countries, with many variables harmonised across cohorts, enabling the examination of the same factors and pathways across contexts.
Another strength was that the cohorts were enrolled
either during pregnancy or at 6 or 9 months post
partum and followed prospectively through 18 months
post partum, allowing these risk factors to be examined
throughout a large portion of the first 1000 days after
conception. The prospective design allowed associations
in the path model to be drawn from variables measured
at earlier time points (eg, pregnancy, birth) to variables
measured at later time points (eg, 6 months, 18 months),
reducing the risk of reverse causality. However, this does
not prevent the possibility of residual confounding, that
is, unmeasured variables accounting for observed associations, therefore we are not able to establish causality.
Another limitation was that we were not able to explore
certain risk factors, such as asymptomatic infections or
enteric dysfunction. We reported multiple comparisons;
therefore, may have found some false positive associations due to chance. However, we reduced this possibility
by reporting p values corrected for multiple comparisons
and by basing our primary conclusions on findings that
were replicated in more than one cohort. These samples
may not be representative of their populations due to
their participation in the nutritional supplementation
trials. However, any bias introduced by the supplementation would be expected to decrease rather than increase
the strength of the associations.31 Therefore, our conclusions regarding consistent significant associations would
remain the same.
Conclusion
Our findings may help to inform the design of interventions to pursue United Nations’ Sustainable Development
Goal 2, to end hunger and achieve improved nutrition
by 2030, with the reduction of stunting prevalence as a
key indicator of progress towards this goal. The evidence
we present shows that child linear growth status is closely
linked to higher maternal height and BMI, fetal growth,
full-term birth, improved household water supply, higher
child dietary diversity, Hb during infancy and reduced
childhood diarrhoea incidence, but we did not find
associations with maternal iron status, illness and inflammation during pregnancy (including maternal HIV
infection in the one cohort in which it was measured),
maternal stress and depression, exclusive breastfeeding
9
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Another study using population-based surveys from 54
countries estimated that mothers in the lowest category
of height (<145 cm) were 2.1 times more likely to have
stunted children than mothers in the highest category
(≥160 cm).8
The key risk factors for linear growth faltering that
we identified were similar to those identified in these
studies despite several differences in methodology,
including prospective cohorts rather than cross-sectional
design, examination of both direct and indirect associations through path analysis, and examination of LAZ
as a continuous variable rather than stunting cases. By
analysing associations with LAZ, we were able to estimate
the difference in LAZ with each SD change in predictor
variables. Each SD difference in maternal height (5–6
cm) was associated with 0.25 difference in LGAZ at birth
(0.5 cm) and a 0.2–0.3 difference in child 18-month LAZ
(0.5–0.8 cm). Each SD difference in LGAZ at birth (1.9
cm) was associated with about a 0.5 difference in child
18-month LAZ (1.4 cm). Each SD difference in gestational age at birth (1.8 weeks) was associated with a
0.13–0.17 difference in 18-month LAZ (0.3–0.5 cm). The
coefficient sizes for the other key risk factors (maternal
BMI, improved water source, dietary diversity, child diarrhoea and Hb) were smaller in magnitude (0.06–0.12).
Despite the examination of 42 environmental,
maternal, caregiving and child factors measured longitudinally throughout most of the first 1000 days, our
models accounted for a relatively small proportion of
the variance in 18-month LAZ (17%–37%), and a large
proportion of that was due to maternal height (10%–
14%). Factors that were not associated with LAZ were
indicators of maternal iron status, illness and inflammation during pregnancy, maternal stress, depression and
cognition, exclusive breast feeding during 6 months post
partum, infant feeding frequency and child fever, malaria
and acute respiratory infections. Variance that remained
unaccounted for could be due to unmeasured factors,
such as enteric dysfunction, asymptomatic infections,
microbiome composition, maternal HIV status or aspects
of the diet that were not assessed. It is also possible that
population-level factors, such as community sanitation or
access to healthcare, may be stronger drivers of growth
stunting compared with individual or household-level
factors.
Our finding that the pooled analysis accounted for more
variance in LAZ (25%) compared with separate analyses by cohort (11%–21%) also supports this argument,
although this difference is not very large. Excluding the
variance accounted for by maternal height, the pooled
analysis accounted for two to three times the variance in
LAZ (16%) compared with the separate cohort models
(5%–8%). This may be due to the lack of inclusion of
a cohort experiencing healthy growth. All four iLiNS
cohorts experienced growth faltering, although the
cohorts in Malawi and Burkina Faso had faltered 1.5–1.9
SD below the WHO median on average, compared with
the Ghanaian children whose mean LAZ was only 0.8
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